Atenção!


O atendimento às questões referentes ao Repositório Institucional será interrompido entre os dias 20 de dezembro de 2025 a 4 de janeiro de 2026.

Pedimos a sua compreensão e aproveitamos para desejar boas festas!

Logo do repositório

Capacity of community health centers to treat snakebite envenoming in indigenous territories of the Brazilian Amazon

dc.contributor.authorSachett, André
dc.contributor.authorStrand, Eleanor
dc.contributor.authorSerrão-Pinto, Thiago
dc.contributor.authorda Silva Neto, Alexandre
dc.contributor.authorPinto Nascimento, Thais
dc.contributor.authorRodrigues Jati, Sewbert
dc.contributor.authordos Santos Rocha, Gisele
dc.contributor.authorAmbrósio Andrade, Sediel
dc.contributor.authorWen, Fan Hui
dc.contributor.authorBerto Pucca, Manuela [UNESP]
dc.contributor.authorVissoci, João
dc.contributor.authorGerardo, Charles J.
dc.contributor.authorSachett, Jacqueline
dc.contributor.authorSeabra de Farias, Altair
dc.contributor.authorMonteiro, Wuelton
dc.contributor.institutionUniversidade do Estado do Amazonas
dc.contributor.institutionFundação de Medicina Tropical Dr. Heitor Vieira Dourado
dc.contributor.institutionDuke University School of Medicine
dc.contributor.institutionUniversidade Federal do Amazonas
dc.contributor.institutionSecretaria de Estado de Educação e Cultura de Roraima
dc.contributor.institutionInstituto Butantan
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2025-04-29T19:35:22Z
dc.date.issued2024-04-01
dc.description.abstractIntroduction: The deaths from and morbidities associated with snakebites - amputations, loss of function in the limb, visible scarring or tissue damage - have a vast economic, social, and psychological impact on indigenous communities in the Brazilian Amazon, especially children, and represent a real and pressing health crisis in this population. Snakebite clinical and research experts have therefore proposed expanding antivenom access from only hospitals to include the community health centers (CHC) located near and within indigenous communities. However, there are no studies examining the capacity of CHCs to store, administer, and manage antivenom treatment. In response to this gap, the research team calling for antivenom decentralization developed and validated an expert-based checklist outlining the minimum requirements for a CHC to provide antivenom. Methods: The objective of this study was thus to survey a sample of CHCs in indigenous territories and evaluate their capacity to provide antivenom treatment according to this accredited checklist. The checklist was administered to nurses and doctors from 16 CHCs, two per indigenous district in Amazonas/Roraima states. Results: Our results can be conceptualized into three central findings: 1) most CHCs have the capacity to provide antivenom treatment, 2) challenges to capacity are human resources and specialized items, and 3) antivenom decentralization is feasible and appropriate in indigenous communities. Conclusion: Decentralization would provide culturally and contextually appropriate care accessibility to a historically marginalized and underserved population of the Brazilian Amazon. Future studies should examine optimal resource allocation in indigenous territories and develop an implementation strategy in partnership with indigenous leaders. Beyond the indigenous population, the checklist utilized could be applied to community health centers treating the general population and/or adapted to other low-resource settings.en
dc.description.affiliationEscola Superior de Ciências da Saúde Universidade do Estado do Amazonas
dc.description.affiliationDiretoria de Ensino e Pesquisa Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
dc.description.affiliationDepartment of Emergency Medicine Duke University School of Medicine
dc.description.affiliationFaculdade de Ciências Farmacêuticas Universidade Federal do Amazonas
dc.description.affiliationSecretaria de Estado de Educação e Cultura de Roraima
dc.description.affiliationInstituto Butantan
dc.description.affiliationDepartamento de Análises Clínicas Faculdade de Ciências Farmacêuticas de Araraquara Universidade Estadual Paulista
dc.description.affiliationUnespDepartamento de Análises Clínicas Faculdade de Ciências Farmacêuticas de Araraquara Universidade Estadual Paulista
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado do Amazonas
dc.description.sponsorshipFogarty International Center
dc.description.sponsorshipNational Institutes of Health
dc.description.sponsorshipRadcliffe Institute for Advanced Study, Harvard University
dc.description.sponsorshipMinistério da Saúde
dc.identifierhttp://dx.doi.org/10.1016/j.toxicon.2024.107681
dc.identifier.citationToxicon, v. 241.
dc.identifier.doi10.1016/j.toxicon.2024.107681
dc.identifier.issn1879-3150
dc.identifier.issn0041-0101
dc.identifier.scopus2-s2.0-85187984754
dc.identifier.urihttps://hdl.handle.net/11449/304553
dc.language.isoeng
dc.relation.ispartofToxicon
dc.sourceScopus
dc.subjectAccessibility
dc.subjectAffordability
dc.subjectAntivenom
dc.subjectIndigenous populations
dc.subjectPreparedness
dc.subjectSnakebite envenoming
dc.titleCapacity of community health centers to treat snakebite envenoming in indigenous territories of the Brazilian Amazonen
dc.typeArtigopt
dspace.entity.typePublication
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.author.orcid0000-0001-6078-4941 0000-0001-6078-4941[1]
unesp.author.orcid0000-0003-1871-1903 0000-0003-1871-1903 0000-0003-1871-1903[6]
unesp.author.orcid0000-0002-8047-3005 0000-0002-8047-3005[7]
unesp.author.orcid0000-0003-1921-4888 0000-0003-1921-4888[14]
unesp.author.orcid0000-0002-0848-1940 0000-0002-0848-1940[15]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt

Arquivos